Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis

Splanchnic and systemic hemodynamics and plasma levels of aldosterone, glucagon and plasma renin were investigated in 12 patients with advanced cirrhosis before and 2 wk (14.6 ± 2.8 days) and 2 mo (60.8 ± 10.5 days) after orthotopic liver transplantation. Liver transplant was followed by significant (p < 0.01) changes in systemic hemodynamics at 2 wk, with a marked reduction in cardiac index (4.9 ± 0.8 vs. 3.7 ± 0.7 L/min ± m2) and increases in mean arterial pressure (79 ± 8 vs. 101 ± 11 mm Hg) and peripheral vascular resistance (721 ± 149 vs. 1,274 ± 253 dyn ± sec ± cm−5). Two months after liver transplant, we saw further significant increases in peripheral vascular resistance (1,700 ± 341 dyn ± sec ± cm−5; p<0.05) without changes in cardiac index. Hepatic venous pressure gradient, very high before transplantation, was normal 2 wk after liver transplant (18.7 ± 3.0 vs. 2.1 ± 0.8 mm Hg; p < 0.01). Hepatic blood flow rose markedly from 1.03 ± 0.46 to 2.25 ± 0.79 L/min (p < 0.01) and was still elevated at 2 mo (1.84 ± 0.74 L/min). Azygos blood flow had not changed after 2 wk with respect to pretransplant values (0.65 ± 0.26 vs. 0.69 ± 0.39 L/min) but had decreased significantly at 2 mo (0.39 ± 0.16 L/min; p < 0.05). The elevated aldosterone, plasma renin and glucagon levels found in our cirrhotic patients before transplantation decreased to near‐normal values 2 wk after the procedure. These results suggest that most of the hemodynamic and humoral abnormalities characteristic of advanced cirrhosis are reversed after liver transplant. However, azygos blood flow remains high early after liver transplant but is decreased at 2 mo, indicating that the closure of porto‐collateral vessels occurs slowly despite the rapid normalization of portal pressure. The increase in hepatic blood flow after liver transplant may be a consequence of hepatic denervation. (HEPATOLOGY 1993;17:355–360.)

[1]  R. Groszmann The Measurement of Liver Blood Flow Using Clearance Techniques , 2007, Hepatology.

[2]  W. Jiménez,et al.  Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide , 1992, Hepatology.

[3]  M. Kutner,et al.  High cardiac output of advanced liver disease persists after orthotopic liver transplantation , 1992, Hepatology.

[4]  S. Moncada,et al.  Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension , 1992, British journal of pharmacology.

[5]  M. Kutner,et al.  The effect of liver denervation on hepatic hemodynamics during hypovolemic shock in swine , 1992, Hepatology.

[6]  R. Wiesner,et al.  Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation. , 1991, Transplantation.

[7]  B. Morgan,et al.  Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. , 1990, New England Journal of Medicine.

[8]  T. Inagami,et al.  Role of endothelin in cyclosporine-induced glomerular dysfunction. , 1990, Kidney international.

[9]  M. Navasa,et al.  Hemodynamic effects of glucagon in portal hypertension , 1990, Hepatology.

[10]  H. Bismuth,et al.  Orthotopic liver transplantation with hepatic artery anastomoses. Hemodynamics and response to hemorrhage in conscious rats. , 1990, Transplantation.

[11]  M. Kutner,et al.  Increased galactose clearance after liver transplantation: A measure of increased blood flow through the denervated liver? , 1989, Hepatology.

[12]  G. Vlasuk,et al.  Enhanced release of atrial natriuretic factor by endothelin in atria from hypertensive rats. , 1989, Hypertension.

[13]  M. Navasa,et al.  Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function. , 1989, Gastroenterology.

[14]  D. Clements,et al.  Indocyanine green clearance in acute rejection after liver transplantation. , 1988, Transplantation.

[15]  Vicente Arroyo,et al.  Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.

[16]  M. Navasa,et al.  Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. , 1988, Gastroenterology.

[17]  P. Weidle,et al.  Systemic Hypertension Associated with Cyclosporine: A Review , 1988, Drug intelligence & clinical pharmacy.

[18]  G. Sanz,et al.  Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extraction , 1988, Hepatology.

[19]  W W Lautt,et al.  Conceptual review of the hepatic vascular bed , 1987, Hepatology.

[20]  R. Webb,et al.  Cyclosporine augments reactivity of isolated blood vessels. , 1987, Life sciences.

[21]  R. Groszmann,et al.  Increased blood flow through the portal system in cirrhotic rats. , 1984, Gastroenterology.

[22]  R. Groszmann,et al.  Measurement of Azygos Venous Blood Flow by a Continuous Thermal Dilution Technique: An Index of Blood Flow Through Gastroesophageal Collaterals in Cirrhosis , 1984, Hepatology.

[23]  V. Arroyo,et al.  Effect of angiotensin‐ll blockade on systemic and hepatic haemodynamics and on the renin‐angiotensin‐aldosterone system in cirrhosis with ascites , 1981, European journal of clinical investigation.

[24]  J. Bruix,et al.  Measurement of hepatic blood flow, hepatic extraction and intrinsic clearance of indocyanine green in patients with cirrhosis. Comparison of a non-invasive pharmacokinetic method with measurements using hepatic vein catheterization , 1991 .

[25]  S. Keiding Hepatic clearance and liver blood flow. , 1987, Journal of hepatology.

[26]  J. Bruix,et al.  Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients. , 1985, Journal of hepatology.

[27]  G. Wilkinson,et al.  Altered Hepatic Blood Flow and Drug Disposition , 1976, Clinical pharmacokinetics.

[28]  G. Paumgartner The handling of indocyanine green by the liver. , 1975, Schweizerische medizinische Wochenschrift.